Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) traded at $1.56 at close of the session on Monday, April 29, made a downward move of -1.27% on its previous day’s price.
Looking at the stock we see that its previous close was $1.58. In terms of its 52-week price range, LXRX has a high of $3.79 and a low of $0.92. The company’s stock has lost about -35.00% over that past 30 days.
Lexicon Pharmaceuticals Inc has a market cap of $384.13 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.2, with the EPS growth for the year raised at -$0.71 for 2024 and -$0.66 for next year. These figures represent 10.10% and 7.00% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.37 million, with a low of $1 million and a high of $2.1 million. The median projection represents growth squeezing down to 5,608.30% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $25.81 million, or 2,043.70% up from figures reported last year.
On the other hand, looking at the outlook for the LXRX stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -16.43% off its SMA20 and -30.00% from its 50-day simple moving average. The RSI (14) is pointing at 33.16 while the volatility over the past week is 7.19% and jumps to 6.93% over the past one month. The beta value is 1.35, while the average true range (ATR) is currently pointing at 0.15.
Coming back to Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), we note that the average 3-month trading volume was 4.56 million. Current shares outstanding are 244.92 million.
The insiders hold 2.72% of the company’s shares while institutions hold 73.90%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 1.96% up in year-to-date price movement.
